Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders.

Okhuijsen-Pfeifer C, van der Horst MZ, Bousman CA, Lin B, van Eijk KR, Ripke S, Ayhan Y, Babaoglu MO, Bak M, Alink W, van Beek H, Beld E, Bouhuis A, Edlinger M, Erdogan IM, Ertuğrul A, Yoca G, Everall IP, Görlitz T, GROUP (Genetic Risk and Outcome of Psychosis) investigators, Grootens KP, Gutwinski S, Hallikainen T, Jeger-Land E, de Koning M, Lähteenvuo M, Legge SE, Leucht S, Morgenroth C, Müderrisoğlu A, Narang A, Pantelis C, Pardiñas AF, Oviedo-Salcedo T, Schneider-Thoma J, Schreiter S, Repo-Tiihonen E, Tuppurainen H, Veereschild M, Veerman S, de Vos M, Wagner E, Cohen D, Bogers JPAM, Walters JTR, Yağcıoğlu AEA, Tiihonen J, Hasan A, Luykx JJ

Open source

DOI
10.1038/s41398-022-01884-3
Published
2022 Apr 7
Container
Translational psychiatry
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41398-022-01884-3,
  title = {Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders.},
  author = {Okhuijsen-Pfeifer C and van der Horst MZ and Bousman CA and Lin B and van Eijk KR and Ripke S and Ayhan Y and Babaoglu MO and Bak M and Alink W and van Beek H and Beld E and Bouhuis A and Edlinger M and Erdogan IM and Ertuğrul A and Yoca G and Everall IP and Görlitz T and GROUP (Genetic Risk and Outcome of Psychosis) investigators and Grootens KP and Gutwinski S and Hallikainen T and Jeger-Land E and de Koning M and Lähteenvuo M and Legge SE and Leucht S and Morgenroth C and Müderrisoğlu A and Narang A and Pantelis C and Pardiñas AF and Oviedo-Salcedo T and Schneider-Thoma J and Schreiter S and Repo-Tiihonen E and Tuppurainen H and Veereschild M and Veerman S and de Vos M and Wagner E and Cohen D and Bogers JPAM and Walters JTR and Yağcıoğlu AEA and Tiihonen J and Hasan A and Luykx JJ},
  year = {2022},
  journal = {Translational psychiatry},
  doi = {10.1038/s41398-022-01884-3},
  url = {https://doi.org/10.1038/s41398-022-01884-3}
}

RIS

TY  - JOUR
TI  - Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders.
AU  - Okhuijsen-Pfeifer C
AU  - van der Horst MZ
AU  - Bousman CA
AU  - Lin B
AU  - van Eijk KR
AU  - Ripke S
AU  - Ayhan Y
AU  - Babaoglu MO
AU  - Bak M
AU  - Alink W
AU  - van Beek H
AU  - Beld E
AU  - Bouhuis A
AU  - Edlinger M
AU  - Erdogan IM
AU  - Ertuğrul A
AU  - Yoca G
AU  - Everall IP
AU  - Görlitz T
AU  - GROUP (Genetic Risk and Outcome of Psychosis) investigators
AU  - Grootens KP
AU  - Gutwinski S
AU  - Hallikainen T
AU  - Jeger-Land E
AU  - de Koning M
AU  - Lähteenvuo M
AU  - Legge SE
AU  - Leucht S
AU  - Morgenroth C
AU  - Müderrisoğlu A
AU  - Narang A
AU  - Pantelis C
AU  - Pardiñas AF
AU  - Oviedo-Salcedo T
AU  - Schneider-Thoma J
AU  - Schreiter S
AU  - Repo-Tiihonen E
AU  - Tuppurainen H
AU  - Veereschild M
AU  - Veerman S
AU  - de Vos M
AU  - Wagner E
AU  - Cohen D
AU  - Bogers JPAM
AU  - Walters JTR
AU  - Yağcıoğlu AEA
AU  - Tiihonen J
AU  - Hasan A
AU  - Luykx JJ
PY  - 2022
JO  - Translational psychiatry
DO  - 10.1038/s41398-022-01884-3
UR  - https://doi.org/10.1038/s41398-022-01884-3
ER  -

APA

C, O., MZ, V. D. H., CA, B., B, L., KR, V. E., S, R., Y, A., MO, B., M, B., W, A., H, V. B., E, B., A, B., M, E., IM, E., A, E., G, Y., IP, E., T, G., investigators, G. (. R. A. O. O. P., KP, G., S, G., T, H., E, J., M, D. K., M, L., SE, L., S, L., C, M., A, M., A, N., C, P., AF, P., T, O., J, S., S, S., E, R., H, T., M, V., S, V., M, D. V., E, W., D, C., JPAM, B., JTR, W., AEA, Y., J, T., A, H., & JJ, L. (2022). Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders.. Translational psychiatry. https://doi.org/10.1038/s41398-022-01884-3

Source records